Cefuroxime sodium
- Product NDC
- 25021-183
- 11-digit product format
- 250210183
- Labeler code
- 25021
- Product ID
- 25021-183_3013653c-01f3-4ec7-a7fa-3e7b49adc4f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefuroxime sodium
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA064125
- Marketing category
- ANDA
- Marketing start
- 2016-09-01
- Marketing end
- 0000-00-00
- Substance
- CEFUROXIME SODIUM
- Active strength
- 2 g/16mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-183-67 | 25021018367 | 25 VIAL in 1 CARTON (25021-183-67) > 16 mL in 1 VIAL | 25 vial | 2016-09-01 | 0000-00-00 | No | No | Current |